Abstract
This article aims to provide a brief overview of the evidence and mechanisms for psilocybin use in EOL care. Additionally, this article will provide guidelines for clinicians to assess patient use and integrate psilocybin into their clinical practice with respect to its current legal status.
First Page
47
Last Page
55
DOI
10.26890/hntj1494
Recommended Citation
Unsworth ME, Galantino ML, Sandoval R. The Role of Psilocybin in End-of-Life Care: Evidence, Mechanisms, and Guidelines. Oncology Rehabilitation in Practice. 2025; 2(2):47-55. doi: 10.26890/hntj1494.
Included in
Alternative and Complementary Medicine Commons, Chemicals and Drugs Commons, Natural Products Chemistry and Pharmacognosy Commons, Occupational Therapy Commons, Pharmacy Administration, Policy and Regulation Commons, Physical Therapy Commons, Psychiatric and Mental Health Commons